Elevance Health Inc.

    Jurisdiction
    United States
    LEI
    8MYN82XMYQH89CTMTH67
    ISIN
    US0367521038 (ELV)
    Sectors
    1. Healthcare
    2. Medical - Healthcare Plans

    Scores

    InsiderPie Expert Score
    75 / 100
    Better than peer group:
    62 / 100
    Fair value (Benjamin Graham formula)
    €548.79 77.5% undervalued
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. Read full profile

    Fundamentals

    Net revenue
    €161.42B
    Gross margin
    57.8%
    EBIT
    €6.09B
    EBIT margin
    3.8%
    Net income
    €4.57B
    Net margin
    2.8%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €176.66B +9.4% €5.67B +24.0%
    €185.53B +5.0% €6.49B +14.4%
    €199.60B +7.6% €7.72B +19.1%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $1.28
    Ex date
    Payment date
    Dividend payout ratio
    29.8%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    DeVore Susan D. N/A +1.2K $312.15 +$374.58K
    BOUDREAUX GAIL President and CEO +8.5K $286.94 +$2.44M

    Congress transactions

    Name Transaction date Value
    Gilbert Cisneros September 12, 2025 $1.00K–$15.00K
    Val Hoyle September 12, 2025 $1.00K–$15.00K
    Val Hoyle September 12, 2025 $1.00K–$15.00K
    Lisa McClain September 12, 2025 $1.00K–$15.00K
    Lisa McClain August 13, 2025 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    James Anderson 2.3M $1.00B -184K Sell
    John Harris 1.1M $488.43M -21K Sell
    Ray Dalio 83K $36.25M -71K Sell

    Earnings Calls

    Add to watchlist

    Notifications